From January 1, 2023 to January 9, 2023, the company has repurchased 614,400 shares, for CNY 3.75 million. With this, the company has completed the repurchase of 8,915,893 shares, for CNY 60 million under the buyback announced on March 10, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.73 CNY | +0.21% | +1.94% | -14.47% |
1st Jan change | Capi. | |
---|---|---|
-14.47% | 457M | |
+20.70% | 43.77B | |
+28.30% | 22.83B | |
+18.68% | 14.34B | |
+54.86% | 12.96B | |
-0.05% | 6.79B | |
-11.53% | 6.41B | |
-8.87% | 5.73B | |
+12.21% | 5.69B | |
+9.49% | 4.75B |
- Stock Market
- Equities
- 603669 Stock
- News Lionco Pharmaceutical Group Co.,Ltd.
- Tranche Update on Lionco Pharmaceutical Group Co.,Ltd.'s Equity Buyback Plan announced on March 10, 2022.